
The laboratory revenue cycle has become unforgiving in 2026. The greatest example of this comes from the CMS, which now pays $127.28 per square centimeter for skin substitutes. Before this, the reimbursements were based on the Average Sales Price (ASP) plus 6% methodology, which was easier to work with for billing teams. The per square centimeter pricing changes that.
And the challenge is still not over yet. Every claim gets audited using AI-powered programs. This virtually leaves zero margin of error.
Yet, a majority of medical billing companies continue to treat lab claims the same way as other office visits. This one-size-fits-all approach costs laboratories 5-15% of collectable revenue.
If your laboratory is experiencing a similar financial impact, it is probably because you are working with a generalist medical billing company. Now, this doesn’t mean that hiring a medical billing company that provides RCM services to different specialties and care settings is strictly a no-go. But you have to be sure that the company you enter into a contract with has laboratory-specific expertise.
In this blog, we are going to discuss major red flags that can help you identify your current or prospective billing partner’s lack of expertise in lab RCM.
Billing companies that don’t have expertise in lab RCM push your lab claims through the same workflow they use for other medical claims. But how to know this before the effect appears on your margins? Below are 8 operational blind spots that you should look out for to identify this systemic leakage point.
The biggest failure point in lab revenue cycle occurs when vendors run it on a generic billing infrastructure. Such infrastructures ignore certain high-priority rules, which leads to severe revenue leakage. Those rules include:
Ignoring these rules leads to underpayments and denials, ultimately leading to the loss of 5-15% of collectable revenue.
Not only do the generalist billers use a uniform billing framework for lab claims, they also cannot provide metrics beyond general medical billing KPIs. This means you might never be able to know the root cause of your revenue loss.
The top lab RCM KPIs that your billing partner must be able to track are:
KPI | Target Benchmark
| Why It Matters for Labs
|
|---|---|---|
First-Pass Resolution Rate for MoPath | ≥95% | A lower rate than this indicates systemic coding failures |
Cost-to-Collect per Specimen | <4% of collections | A higher cost percentage can quickly drain your margins as labs have to deal with high specimen volumes. |
Denial Rate by Payer and Test Type | <5% overall | Not tracking denial rates on these parameters makes revenue leakage chronic and more significant |
Days in A/R for Lab Claims | <30 days | Lab claims age quickly due to complex payer rules. And the collection probability with older claims is usually lower. |
Net Collection Rate for Lab Services | 95-97% | A rate below 93% means there is serious revenue leakage in lab-specific adjudication. |
Make sure that you are not partnering with a vendor that requires a 3-month commitment with no clause about service termination in case of poor performance. Here are the reasons why this is a major red flag:
The worst part about such contracts is that you will have no way to identify revenue erosion in real time. You will know about your losses only after they have become significant.
Some billing companies have vague pricing structures with unclear clauses. This gives them systematic loopholes to charge for reporting, patient follow-ups, and even resubmissions. Other than this, they may charge you:
Laboratory margins are usually already thin. These margins become narrower if your billing company charges you extra in the form of hidden fees.
LIS integration and data processing systems today are more advanced and automated than ever. But if your lab billing partner still requires manual data handling from your LIS to their systems, your revenue cycle system will not be able to catch up with the pace of your service provision. Its impact will be in the form of:
Analysis of denial root causes requires properly understanding specific payer policies. Generalist billers are usually unable to get this important knowledge because they have:
All this leaves so many denials unworked. The result is a 3-5% loss of your lab’s revenue.
Billing companies that do not have dedicated lab RCM workflows fail to convince payers who focus on lab services. For this reason, they cannot maintain solid transactional relationships with those payers. As a result, their knowledge of lab LCDs/NCDs remains limited. These billing companies also have very little idea of how state regulations can affect payment timelines.
Generalist billers do not have enough resources and strategy to conduct regular audits to ascertain where they lack in lab RCM. And since they cannot look into their processes, they cannot set up solid frameworks to train their revenue cycle teams. This leads to their failure in complying with CLIA standards.
With this noncompliance, they cause their contracted clinical labs to pay heavy fines and get excluded from federal programs.
All you have to do is focus on some technical requirements, KPI commitments, contract clauses, and compliance records to ensure you are contracting with the right billing company. Let’s elaborate these aspects briefly.
Ask the prospective company whether they offer:
Your billing company should be able to offer the following:
Ensure that your billing company offers:
Last but not least, you should ensure that your billing company has:
When you evaluate laboratory billing companies on these parameters, generalists get filtered out. You get a narrowed down list of vendors with specialized knowledge and expertise in lab RCM.
Laboratory revenue cycle management has become more complex, especially in 2026. Billing companies that do not have specialized expertise, integrated tech, and mastery over lab-specific KPIs do not stand much of a chance. The eight red flags mentioned above should help you remain vigilant about these companies.
Your only option as a lab director is to work with specialists who can improve your cash flow and protect your margins. If you don’t, you will end up diverting resources from diagnostic testing to revenue management. And this will be a leap (not a step) towards the failure of your revenue infrastructure.
Enter Your Email Address. We Promise We Won't Spam You
Enter your email to receive our newsletter, so you can stay in the loop with our latest promos.